KemPharm

KMPH NASDAQ
1.670
+0.080
+5.03%
已收盘, 16:00 06/17 EDT
开盘
1.600
昨收
1.590
最高
1.700
最低
1.600
成交量
9.32万
成交均量(3M)
18.75万
52周最高
6.85
52周最低
1.150
换手率
0.33%
市值
4,762.72万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供KemPharm KMPH股票价格,KemPharm股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is combined with acetaminophen (APAP). The Company is developing KP201/APAP as an immediate release (IR), a product candidate for the short-term, or no longer than 14 days for the management of acute pain. The Company has designed KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse in the United States. The Company also focuses on developing the pipeline of additional prodrug product candidates that targets pain and attention deficit hyperactivity disorder (ADHD). The Company's products include KP201/IR (APAP-free), KP511/ER, KP415, KP606/IR and KP746.
展开 >

最近浏览

名称
价格
涨跌幅